1. Home
  2. ITOS vs GBAB Comparison

ITOS vs GBAB Comparison

Compare ITOS & GBAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • GBAB
  • Stock Information
  • Founded
  • ITOS 2011
  • GBAB 2010
  • Country
  • ITOS United States
  • GBAB United States
  • Employees
  • ITOS N/A
  • GBAB N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • GBAB Investment Managers
  • Sector
  • ITOS Health Care
  • GBAB Finance
  • Exchange
  • ITOS Nasdaq
  • GBAB Nasdaq
  • Market Cap
  • ITOS 450.9M
  • GBAB 400.4M
  • IPO Year
  • ITOS 2020
  • GBAB N/A
  • Fundamental
  • Price
  • ITOS N/A
  • GBAB $15.65
  • Analyst Decision
  • ITOS Hold
  • GBAB
  • Analyst Count
  • ITOS 6
  • GBAB 0
  • Target Price
  • ITOS $10.40
  • GBAB N/A
  • AVG Volume (30 Days)
  • ITOS 1.6M
  • GBAB 69.4K
  • Earning Date
  • ITOS 08-06-2025
  • GBAB 01-01-0001
  • Dividend Yield
  • ITOS N/A
  • GBAB 9.18%
  • EPS Growth
  • ITOS N/A
  • GBAB N/A
  • EPS
  • ITOS N/A
  • GBAB N/A
  • Revenue
  • ITOS N/A
  • GBAB N/A
  • Revenue This Year
  • ITOS N/A
  • GBAB N/A
  • Revenue Next Year
  • ITOS N/A
  • GBAB N/A
  • P/E Ratio
  • ITOS N/A
  • GBAB N/A
  • Revenue Growth
  • ITOS 177.89
  • GBAB N/A
  • 52 Week Low
  • ITOS $4.80
  • GBAB $14.22
  • 52 Week High
  • ITOS $17.63
  • GBAB $17.44
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 1.63
  • GBAB 66.33
  • Support Level
  • ITOS $10.10
  • GBAB $15.21
  • Resistance Level
  • ITOS $10.17
  • GBAB $15.57
  • Average True Range (ATR)
  • ITOS 0.03
  • GBAB 0.17
  • MACD
  • ITOS -1.20
  • GBAB 0.02
  • Stochastic Oscillator
  • ITOS 0.00
  • GBAB 94.20

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About GBAB Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust of Beneficial Interest

Guggenheim Taxable Municipal Managed Duration Trust is a diversified closed-end management investment company. Its investment objective is to provide current income with a secondary objective of long-term capital appreciation. Its products include Mutual funds, Unit investment trusts, Closed-end funds, Rydex funds, Credit income fund and others.

Share on Social Networks: